ChemicalBook > CAS DataBase List > LUMIRACOXIB

LUMIRACOXIB

Product Name
LUMIRACOXIB
CAS No.
220991-20-8
Chemical Name
LUMIRACOXIB
Synonyms
Prexige;COX 189;CGS 35189;Lumaricoxib;LUMIRACOXIB;Unii-V91T9204hu;Prexige, Lumiracoxib;Xanthine Impurity 30;LuMiracoxib (COX-189);Lumiracoxib (CGS 35189
CBNumber
CB21006324
Molecular Formula
C15H13ClFNO2
Formula Weight
293.72
MOL File
220991-20-8.mol
More
Less

LUMIRACOXIB Property

Melting point:
139-141°C
Boiling point:
395.7±42.0 °C(Predicted)
Density 
1.363±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
solubility 
≥29.4 mg/mL in DMSO; insoluble in H2O; ≥27.15 mg/mL in EtOH with ultrasonic
form 
solid
pka
4.18±0.10(Predicted)
color 
White to light yellow
CAS DataBase Reference
220991-20-8
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

Precautionary statements

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
SML2928
Product name
Lumiracoxib
Purity
≥98% (HPLC)
Packaging
10MG
Price
$46.6
Updated
2024/03/01
Sigma-Aldrich
Product number
SML2928
Product name
Lumiracoxib
Purity
≥98% (HPLC)
Packaging
50MG
Price
$191
Updated
2024/03/01
Cayman Chemical
Product number
27645
Product name
Lumiracoxib
Packaging
10mg
Price
$32
Updated
2024/03/01
Cayman Chemical
Product number
27645
Product name
Lumiracoxib
Packaging
50mg
Price
$86
Updated
2024/03/01
Cayman Chemical
Product number
27645
Product name
Lumiracoxib
Packaging
100mg
Price
$153
Updated
2024/03/01
More
Less

LUMIRACOXIB Chemical Properties,Usage,Production

Description

As a second-generation, selective cyclooxygenase (COX-2) inhibitor, lumiracoxib is devoid of the gastrointestinal issues that plague other non-selective, nonsteroidal, anti-inflammatory drugs (NSAIDs) that crossover to COX-1. As an inhibitor of the inducible COX-2 that is up-regulated in pathological processes of pain and inflammation, lumiracoxib blocks the conversion of arachidonic acid to prostaglandins, the mediators of the pathological effects. It’s mode of binding to COX-2 has been found to differ from the other selective COX-2 inhibitors; the carboxylic acid forms hydrogen bonds with Tyr-385 and Ser-530 in the catalytic site rather than seeking interactions within the larger hydrophobic side pocket. Since lumiracoxib is mainly metabolized by CYP2C9, a study evaluating the co-administration of lumiracoxib with fluconazole, a potent inhibitor of CYP2C9, was conducted, and it concluded that there was no need for lumiracoxib dose adjustment, since changes in the systemic exposure were not significant. No serious adverse effects were reported, but in the small number of cases where treatment was discontinued, Gastro intestinal (GI) and musculoskeletal complaints were common.

Description

Lumiracoxib is a selective inhibitor of COX-2 with IC50 values of 0.13 and 67 μM for COX-2 and COX-1, respectively, in isolated human whole blood. It reduces increases in the levels of prostaglandin E2 (PGE2; ) induced by IL-1β in human dermal fibroblasts (IC50 = 0.14 μM), as well as in LPS-stimulated RAW 264.7 cells when used at concentrations ranging from 1 to 100 μM., Lumiracoxib (3 and 10 mg/kg) also decreases LPS-induced increases in the levels of PGE2 in a rat model of air pouch inflammation. It reduces M. tuberculosis-induced increases in hind paw volume and the radiological and histopathological severity of arthritic lesions in a rat model of chronic arthritis when administered at a dose of 2 mg/kg.

Chemical Properties

Pale Yellow Solid

Originator

Novartis AG (Switzerland)

Uses

Lumiracoxib is a selective cyclooxygenase-2-(COX-2) inhibitor and an anti-inflammatory agent (1,2,3,4).

Uses

Selective cyclooxygenase-2-(COX-2) inhibitor. Anti-inflammatory.

Uses

antiinflammatory, analgesic, antiarthritic

Definition

ChEBI: An amino acid that is phenylacetic acid which is substituted at position 2 by the nitrogen of 2-chloro-6-fluoroaniline and at position 5 by a methyl group. A highly selective cyclooxygenase 2 inhibitor, it was briefly used for the treatment of osteoarthrit s, but was withdrawn due to concersns of hepatotoxicity.

brand name

Prexige

Biochem/physiol Actions

Lumiracoxib (COX189) is an orally active, potent and selective cyclooxygenase-2 inhibitor (Ki = 60 nM/COX-2 vs. 3.2 μM/COX-1) that inhibits COX-2-mediated PGE2 production in human whole blood (IC50 = 130 nM; stimulation = 50 μM A23187), but not COX-1-dependent TxB2 production (IC50 = 67 μM; stimulation = 10 μg/mL LPS). Lumiracoxib shows in vivo anti-inflammatory efficacy against carrageenan-induced paw oedema (ED30 = 0.35 mg/kg p.o.), CFA-induced hyperalgesia (ED30 = 5.1 mg/kg p.o.), as well as adjuvant-induced arthritis (ED50 = 3 mg/kg/day p.o.) in rats in vivo.

LUMIRACOXIB Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

LUMIRACOXIB Suppliers

Synpha Base AG
Tel
--
Fax
--
Email
office@synphabase.ch
Country
Switzerland
ProdList
13
Advantage
58
SynphaBase AG
Tel
--
Fax
--
Email
info@synphabase.ch
Country
Switzerland
ProdList
628
Advantage
60
More
Less

View Lastest Price from LUMIRACOXIB manufacturers

Hebei Weibang Biotechnology Co., Ltd
Product
LUMIRACOXIB 220991-20-8
Price
US $9.90/KG
Min. Order
1KG
Purity
99%
Supply Ability
10 mt
Release date
2024-11-29
Hebei Mojin Biotechnology Co., Ltd
Product
LUMIRACOXIB 220991-20-8
Price
US $0.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
50000KG/month
Release date
2023-08-28
Longyan Tianhua Biological Technology Co., Ltd
Product
LUMIRACOXIB 220991-20-8
Price
US $30.00/Kg/Bag
Min. Order
1Kg/Bag
Purity
99
Supply Ability
999
Release date
2020-11-09

220991-20-8, LUMIRACOXIBRelated Search:


  • 2-[2-[(2-chloro-6-fluoro-phenyl)amino]-5-methyl-phenyl]acetic acid
  • 2-[(2-Chloro-6-fluorophenyl)amino]-5-methylbenzeneacetic Acid
  • CGS 35189
  • COX 189
  • Prexige
  • Lumaricoxib
  • Benzeneacetic acid, 2-((2-chloro-6-fluorophenyl)amino)-5-methyl-
  • Unii-V91T9204hu
  • Lumiracoxib, COX-189, Prexige
  • LuMiracoxib (COX-189)
  • 2-(5-((2-chloro-6-fluorophenyl)amino)-2-methylphenyl)acetic acid
  • 2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid
  • Lumiracoxib (CGS 35189
  • 2-[2-(2-Chloro-6-fluorophenylamino)-5-methylphenyl]acetic ac...
  • Prexige, Lumiracoxib
  • Cyclooxygenase,Inhibitor,bone cancer,osteoarthritis,inflammatory,COX189,inhibit,hyperalgesic,COX 189,Lumiracoxib,COX,Metabolic Syndrome
  • Xanthine Impurity 30
  • LUMIRACOXIB
  • 220991-20-8
  • C15H13ClFNO2
  • Inhibitors
  • PREXIGE
  • Aromatics Compounds
  • Aromatics
  • Intermediates & Fine Chemicals
  • Pharmaceuticals